Skip to main content
Clinical Trials/IRCT20220907055908N1
IRCT20220907055908N1
Recruiting
Phase 3

Investigating the anti-inflammatory effect of colchicine in patients undergoing coronary artery bypass graft (CABG) in Semnan kosar hospital in 1401: A randomized clinical trial

Semnan University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Coronary Artery Disease.
Sponsor
Semnan University of Medical Sciences
Enrollment
90
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Semnan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • patients over 30 years old and under 80 years old
  • patients needing CABG surgery
  • Informed consent

Exclusion Criteria

  • patients should have contraindications to colchicine or atorvastatin
  • patients with a history of severe liver diseases
  • patients who have creatinine clearance less than 50\.
  • patients with a history of atrial fibrillation or atrial flutter or 2nd and 3rd\-degree heart block
  • patients with autoimmune diseases or a history of taking immunosuppressive drugs in the last 1 month
  • patients with heart failure Ejection Fraction \< 35%
  • patients with a history of muscle conflicts
  • patients of taking fibrate drugs
  • patients with leukopenia or active infection
  • patients with acute coronary syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials